Roche RHHBY is set to enter the competitive continuous glucose monitor (CGM) market in Europe following the CE mark approval of its Accu-Chek Smartguide in July. The Swiss pharmaceutical company plans ...

The integration of Accu-Chek SmartGuide's AI-enabled predictive CGM with the popular mySugr app delivers a simple, intuitive solution for people to manage their diabetes with greater ease. Accu-Chek ...

Roche Holding RHHBY recently announced that it has received the CE Mark for its Accu-Chek SmartGuide continuous glucose monitoring (CGM) solution. With the approval, CGM solution can now be made ...

Roche raised the curtain on its upcoming continuous glucose monitoring system featuring artificial intelligence-powered forecasts of blood sugar highs and lows. At the International Conference on ...

Pharmaceuticals maker Roche overhauled its blood glucose monitoring system and introduced a new discounting offer that it says could save uninsured diabetics by thousands of dollars per year. The move ...

INDIANAPOLIS, Oct. 1, 2012 — Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the ACCU-CHEK Combo system for insulin pump therapy is now available in the United States. This market launch ...

History: Roche Diagnostics Corp. is a division of Roche, the world’s largest biotech company and a global pioneer in pharmaceuticals and diagnostics. The Indianapolis division began as locally based ...

Accu-Chek manufactures blood glucose meters that people can use to monitor their diabetes. People can purchase bundles and subscriptions through the company’s website. Share on Pinterest This article ...

BASEL, Switzerland, Sept. 16, 2025 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) shared real-world evidence from the rollout of Accu-Chek SmartGuide continuous glucose monitoring (CGM) solution ...